Stay updated on Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study content. This blocks access to the study details and locations that were previously visible.
    Difference
    17%
    Check dated 2026-09-20T01:43:10.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor patch to the page's metadata or formatting rather than changes to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-29T23:55:18.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5. This indicates a behind-the-scenes update to the site without changing the displayed study information.
    Difference
    0.1%
    Check dated 2026-08-08T18:26:41.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.4, reflecting a software update. No clinical content or trial details were changed.
    Difference
    0.1%
    Check dated 2026-07-25T10:22:43.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.3) has been added, replacing the previous v3.6.2 to indicate a recent content update.
    Difference
    0.1%
    Check dated 2026-07-03T22:47:02.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a deployment patch. This appears to be an internal update and does not reflect changes to study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.